Yes! 404 varieties transferred out of medical insurance

On December 13, Hunan Medical Insurance Bureau and the Department of human resources and Social Security jointly issued the notice on the practical implementation The notice is clear and strictly in accordance with the national regulations The 2019 version of the national medical insurance catalogue will be officially implemented from January 1, 2020 No adjustment or other development of the medical insurance catalogue in any name is allowed, and no adjustment of the proportion of self payment and restriction of the scope of use is allowed In addition, the notice emphasizes that the drugs supplemented by the original province will be digested year by year, the first batch of national key monitoring catalog varieties will be removed preferentially, and the original catalog varieties of the province that have entered the national drug catalog will be classified as the "drugs in digestion period" These varieties will be digested year by year within three years according to the national regulations, and the scope of medical insurance will be cleared According to the past practice, almost every round of adjustment of the national health insurance catalogue will give each province and city an opportunity to supplement And this round of medical insurance catalog adjustment, from the National Health Insurance Bureau issued the catalog adjustment notice, has already hinted that the local medical insurance supplement will eventually become history On August 20, the State Health Insurance Bureau officially issued the 2019 version of the national health insurance catalogue, which mentioned in the item of "clear local authority": "for class B drugs increased according to regulations in the original provincial drug catalogue, they should be gradually digested within three years" and "provinces should give priority to adjusting the drugs included in the national key monitoring scope out of the payment scope" Recently, not only Hunan Province, but also Guangdong, Tianjin, Zhejiang and other places have issued papers successively to carry out the docking work between the provincial directory and the new version of the national medical insurance directory From the current situation, all provinces have achieved the key monitoring directory drugs first moved out of the medical insurance directory Although some regions haven't cleared up the local supplementary varieties, with the development of time, the local medical insurance catalogue will become a historical trend With the medical insurance supplement catalogue digested and cleaned up year by year in three years, the last straw of many supplement varieties will be lost Jia Xiaoqing, the purchasing manager of the retail department of Jiangsu Pharmaceutical Co., Ltd., told cypress blue that the national standards are unified and the management is becoming more strict All regions are not allowed to make their own catalogues or use flexible methods to supplement the drugs in the catalogues, or adjust the limited payment scope of the drugs in the catalogues, and the local supplement power is basically cancelled Before this, only relying on entering the local supplement catalogue to support sales Amount of varieties will have a greater impact, this kind of varieties is basically equal to kick out of the hospital market He believes that with the transfer in and out of the medical insurance catalog, the structure of market results will change significantly Auxiliary drugs and drugs with unclear clinical value are further compressed, and the prerequisite for being transferred into the medical insurance catalog is: clinical necessity and definite curative effect Under the influence of the adjustment of the national medical insurance catalog and the docking of the national medical insurance catalog and the local medical insurance, pharmaceutical enterprises will face the following problems: According to the notice on printing and distributing the first batch of national key monitoring and rational drug catalog (chemical and biological products) issued by the national health and Health Commission, western medicine that fails to meet the requirements cannot issue prescriptions for Chinese patent medicine According to the 2018 statistical bulletin on the development of China's health care industry, only 16% of Chinese medicine practitioners (Assistant) are doctors (see the table below) If this policy is strictly implemented, the market of Chinese patent medicine and Chinese herbal pieces will face a big shuffle However, with the clearing of the medical insurance supplement catalogue, the provincial supplement varieties that do not enter the national medical insurance, as well as the provincial supplement varieties that belong to the key monitoring drugs, especially the varieties of Chinese patent medicines, will face a serious blow The new edition of the national medical insurance catalogue clearly stipulates that clinical necessity and curative effect are the primary conditions for inclusion in the catalogue Combined with the list of key monitoring drugs for rational use issued by the national health and Health Commission, we can find that the clinical use of drugs will be changed from abuse to regular use, and the national medical insurance funds can be really used on the blade In the future, evidence-based medicine research is the way that pharmaceutical enterprises must go There is only one way - the market has to be rediscovered in three years.